Half of the patients who received an experimental vaccine for pancreas cancer being developed by Roche and BioNTech following surgery in a small, early trial were stil

Pancreatic cancer is one of the deadliest and most difficult-to-detect forms of cancer. It kills nearly half a million people annually and has a five-year survival rate of less than 15 percent. The main challenge is that there are no reliable tools to detect the disease at early stages,

Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced stages when the disease has already spread, or metastasized.

A ‘tumour-on-chip’ model on PDAC has been developed to allow insights into interactions between tumour cells and potential treatments.

Scientists at Oregon Health and Science University (OHSU) have developed a new blood test for pancreatic cancer, one of the most deadly forms of the disease. Tests showed up to 85% accuracy in detection,

Paired with an existing test, this could become a life-saving diagnostic tool for people with a notoriously deadly form of cancer.

Pancreatic cancer reprograms nerve cells to fuel its growth, but blocking these connections can shrink tumors and boost treatment effectiveness. Pancreatic cancer is closely linked to the nervous system,

Pancreatic cancer remains difficult to treat, and is responsible for around 8 percent of all cancer deaths.It also has one of the lower longterm survival rates with only about 13 percent of patients surviving more than five years.

A new assay rapidly detected pancreatic ductal adenocarcinoma and differentiated it from noncancer pancreatic diseases by measuring cancer-associated protease activity in a small amount of blood.

The study followed 16 patients, including Barbara Brigham, who joined the trial after a routine scan discovered her early-stage pancreatic cancer. Alongside surgery and chemotherapy, patients received a customized mRNA vaccine, designed using their own tumors.

Thanks to decades of sustained, predictable federal investments and increases in pancreatic cancer research, the research community is at a [...] READ MORE

Pancreatic cancer is the third leading cause of cancer-related deaths in the country. The Ramone Foundation is hosting a charity boxing event to ease that burden and fund research.